Skip to search formSkip to main contentSkip to account menu

aminaphthone

Known as: 1,4-dihydroxy-3-methyl-2-naphthyl 4-aminobenzoate, 3-methyl-1,2,4-naphthalenetriol-2-(4-aminobenzoate), aminaftone 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

CapilaremaCapillarema

Broader (2)

Hemostatic Agentspara-Aminobenzoates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Abstract 15583: Evaluation of the Efficacy of Aminaftone in a Rat Model of Monocrotaline-induced Pulmonary Hypertension
Introduction: Increased vascular resistances give rise to pulmonary arterial hypertension (PAH), leading to right heart failure… 
2007
2007
Aminaftone down-regulates endothelin-1 production in ECV-304 cells: new facts about an old drug : aminaftone: an old drug for a new therapeutic approach
Review
1995
Review
1995
Chronic Venous Insufficiency without Surgical Possibilities Study with Aminaftone (Capilarema)
Review the benefit of Aminaftone (Capilarema) in patients with chronic venous insufficiency showing occlusive syndromes or deep… 
1985
1985
[Evaluation of the activity of aminaftone as coadjuvant treatment in various traumatic injuries].
1983
1983
[Modification of primary hemostasis and capillary fragility induced by aminaftone in chronic renal insufficiency].
1978
1978
[Therapeutic activity of aminaphthone in purpuric disorders].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)